What They Aren't Telling You About Glucose and Insulin Resistance | Dr. Benjamin Bikman

Quick Overview

Dr. Benjamin Bikman argues that conventional medical advice for Type 2 diabetes, which focuses solely on lowering blood glucose via insulin or drugs like sulfonylureas, is dangerously flawed because it ignores the underlying issue of insulin resistance, leading to increased fat storage, greater risk of chronic diseases, and ultimately, earlier death for patients.

Key Points: Conventional medicine focuses on lowering blood glucose in Type 2 diabetes, often through insulin or sulfonylureas, which Dr. Bikman argues is a flawed approach. Insulin resistance is the root cause of Type 2 diabetes, leading to high insulin levels while blood glucose remains normal. High insulin levels signal fat cells to grow, and the fat cells then become insulin resistant, creating a vicious cycle that leads to increased fat storage. This insulin-centric approach causes patients to be three times more likely to die from heart disease and also increases risks for Alzheimer's and fatty liver disease. Keto-adaptation (burning fat for fuel) promotes ketogenesis, which produces ketones that the brain readily uses instead of glucose, offering a metabolic pathway that bypasses the insulin issue. Type 1 diabetics, who lack insulin production, do not suffer from the same metabolic complications as Type 2 diabetics who rely on insulin to manage high glucose.

Context: This video features an interview between Dr. Jordan Peterson and Dr. Benjamin Bikman, a metabolic scientist, discussing the underlying physiological mechanisms behind insulin resistance and Type 2 diabetes. Bikman critiques the standard medical paradigm that prioritizes blood glucose management over addressing the root cause, insulin resistance, drawing parallels between historical dietary approaches and modern metabolic health.

Detailed Analysis

Dr. Benjamin Bikman critiques the standard medical approach to Type 2 diabetes, which relies on lowering blood glucose levels, often through constant insulin administration or drugs like sulfonylureas (which stimulate insulin release). He explains that this approach is flawed because it fails to address the fundamental problem: insulin resistance. When insulin is high, it signals fat cells to store energy, causing them to grow, which in turn exacerbates insulin resistance. This cycle leads to increased fat storage, and Bikman asserts that this insulin-centric view leads to worse outcomes, including a tripled risk of death from heart disease, and increased risks for fatty liver disease and dementia. He contrasts this with Type 1 diabetes, where the body lacks insulin entirely and patients who strictly limit carbohydrates (like those on a carnivore diet) can manage their condition without the same metabolic pitfalls. Bikman emphasizes that the body prioritizes using up its easily accessible glucose stores (which are constantly replenished by dietary carbohydrates) before tapping into fat stores, meaning that if carbohydrates are continually supplied, the body never enters ketosis or utilizes fat effectively. He concludes that by focusing only on blood glucose, doctors miss the real issue, which is the body's inability to manage fat metabolism due to chronic high insulin, ultimately leading to premature death.